Division of Nephrology and Hypertension Archive — Page 3 of 9
-
October 6, 2022
Kidney diseases research collaboration renewed
Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases. -
October 4, 2022
Vanderbilt’s Terker wins NIH Director’s Early Independence Award
Andrew Terker, MD, PhD, a physician-scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award. -
August 25, 2022
Inflammatory driver of obesity
Blocking the EGF receptor signaling pathway in immune system macrophages represents a new target for improving insulin resistance in people with obesity. -
May 12, 2022
Study sheds light on the dark side of obesity
Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity. -
May 12, 2022
Fissell receives Medal of Excellence from the American Association of Kidney Patients
Vanderbilt's William Fissell, MD, recently received the 2022 Medal of Excellence Award in the physician category from the American Association of Kidney Patients. -
April 13, 2022
Arroyo, Terker receive new awards from ASCI
Juan Pablo Arroyo, MD, PhD, instructor of Medicine in the Division of Nephrology and Hypertension, and Andrew Terker, MD, PhD, research fellow in Nephrology, each received an inaugural 2022 Emerging Generation Award from the American Society for Clinical Investigation. -
April 6, 2022
Schaefer named Adult Solid Organ Transplant Center medical director
Heidi Schaefer, MD, has been named medical director of the Adult Solid Organ Transplant Center at Vanderbilt University Medical Center.